Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice

被引:49
作者
Chen, Chiu-Mei
Yin, Mei-Chin [1 ]
Hsu, Cheng-Chin
Liu, Ting-Chun
机构
[1] China Med Univ, Dept Nutr, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Dept Neurol, Taichung, Taiwan
[3] Chung Shan Med Univ, Dept Nutr Sci, Taichung, Taiwan
关键词
glutathione; tumor necrosis factor-alpha; striatum; Parkinson's disease; dopamine; dopamine transporter; s-propyl cysteine; s-ethyl cysteine; PARKINSONS-DISEASE; OXIDATIVE STRESS; ALPHA-TOCOPHEROL; DOPAMINE TRANSPORTER; MOUSE MODEL; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; NEUROTOXICITY; INFLAMMATION; EXPRESSION; CYTOKINES;
D O I
10.1016/j.nut.2007.05.004
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objectives: Mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) were used to examine the neuroprotective effects of n-acetyl cysteine (NAC), s-ethyl cysteine (SEC), s-methyl cysteine (SMC), and s-propyl cysteine (SPC). Methods: Each agent at 1 g/L was directly added to the drinking water for 3 wk. Mice were treated by subcutaneous injection of MPTP (24 mg/kg body weight) for 6 consecutive days. The brain from each mouse was quickly removed and the striatum was collected for analyses. Results: The MPTP treatment significantly depleted striatal glutathione content, reduced the activity of glutathione peroxidase (GPX), superoxide dismutase (SOD), and catalase, increased malondialdehyde level, and elevated interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) levels in striatum (P < 0.05). The pre-intake of NAC, SEC, SMC, and SPC significantly attenuated MPTP-induced glutathione loss, retained the activity of GPX and SOD, diminished oxidative stress, and suppressed MPTP-induced elevation of IL-6 and TNF-alpha (P. < 0.05). MPTP treatment significantly suppressed GPX mRNA expression and enhanced TNF-a mRNA expression (P < 0.05). Compared with MPTP treatment alone, the pre-intake of NAC, SEC, SMC, and SPC significantly elevated GPX mRNA expression and diminished TNF-a mRNA expression (P < 0.05), in which SPC showed the greatest suppressive effect against MPTP-induced TNF-a mRNA expression (P < 0.05). Dopamine and 3,4-dihydroxyphenylacetic acid contents in the striatum were significantly decreased by MPTP treatment (P < 0.05). The pye-intake of four test agents significantly improved MPTP-induced dopamine depletion and increased dopamine/3,4-dihydroxyphenylacetic acid content (P < 0.05). Conclusion: These results suggest that these cysteine-containing compounds could provide anti-oxidative and anti-inflammatory protection for the striatum against the development of Parkinson's disease. (c) 2007 Elsevier Inc. All rights reserved..
引用
收藏
页码:589 / 597
页数:9
相关论文
共 34 条
[11]   γ-tocopherol attenuates MPTP-induced dopamine loss more efficiently than α-tocopherol in mouse brain [J].
Itoh, Nanako ;
Masuo, Yoshinori ;
Yoshida, Yasukazu ;
Cynshi, Osamu ;
Jishage, Kou-ichi ;
Niki, Etsuo .
NEUROSCIENCE LETTERS, 2006, 403 (1-2) :136-140
[12]   The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins [J].
Jain, SK ;
Palmer, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (04) :593-596
[13]   Biosynthesis of the flavour precursors of onion and garlic [J].
Jones, MG ;
Hughes, J ;
Tregova, A ;
Milne, J ;
Tomsett, AB ;
Collin, HA .
JOURNAL OF EXPERIMENTAL BOTANY, 2004, 55 (404) :1903-1918
[14]   Cysteine sulfoxides and alliinase activity of some Allium species [J].
Krest, I ;
Glodek, J ;
Keusgen, M .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (08) :3753-3760
[15]   Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice [J].
Kurosaki, R ;
Muramatsu, Y ;
Watanabe, H ;
Michimata, M ;
Matsubara, M ;
Imai, Y ;
Araki, T .
METABOLIC BRAIN DISEASE, 2003, 18 (02) :139-146
[16]   Neuroprotective effects of Bak Foong Pill in 1-methyl-4-phenyl-1,2,3,6-tetrahyrdropyridine (MPTP)-induced Parkinson's disease model mice [J].
Liu, B ;
Xie, JX ;
Rowlands, DK ;
Gou, YL ;
Leung, CC ;
Chung, YW ;
Chan, HC .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (08) :1245-1250
[17]  
Liu TZ, 2001, ANN CLIN LAB SCI, V31, P383
[18]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[19]   Dopamine transporters and neuronal injury [J].
Miller, GW ;
Gainetdinov, RR ;
Levey, AI ;
Caron, MG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (10) :424-429
[20]  
Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277